7/9/2013 6:25:19 AM
Melior Discovery, Inc. announced today that it has acquired all of the assets of Biolucidation, LLC and appointed its scientific founder, Dr. Gregory Gatto as Senior Director of Behavioral Pharmacology for Melior Discovery Inc.
Dr. Gatto is a highly accomplished preclinical pharmacology expert with deep experience in the area of drug abuse liability. He has accumulated over 30 years of preclinical pharmacology research experience and over 15 years of pharmaceutical R&D experience in the area of psychiatric disease and cognition.